Lilli Petruzzelli is a natural problem-solver, constantly exploring new ways to tackle the most complex challenges in drug discovery for patients. She also finds balance in life’s simple joys—like spending time with family and baking. As Senior Vice President of Early Clinical Development, Lilli has woven her love of chemistry, dedication to patient care, and passion for problem-solving into a career that bridges research, medicine, and heart. http://spr.ly/61820Wylg | Genentech

At Genentech, we push the boundaries of science, always striving for breakthroughs that could change the future for people living with cancer. With breast cancer affecting millions of people, the need for new medicines inspires our team to give their best every day. Hear their stories on what working in breast cancer means to them. #BreastCancerAwarenessMonth | Genentech

Diffuse large B-cell lymphoma (DLBCL) is an aggressive type of non-Hodgkin’s lymphoma (NHL). It is also the most common type of NHL, accounting for one out of every three lymphomas and affecting almost 31,000 people in the U.S. Learn more about Lamar’s journey with this condition. | Genentech